Advertisement

  • Learning Medicare’s ABCDs

    Medicare was established to help provide affordable health care coverage for older Americans. But Medicare beneficiaries with cancer can still face financial burdens related to their care.

    by Kate Yandell

  • Policy Matters

    Racial and Ethnic Disparities in Multiple Myeloma Clinical Trials

    The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

    by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

  • FORWARD LOOK

    Learning How to Prevent Multiple Myeloma

    Irene Ghobrial on studying cancer precursors.

    by Sue Rochman

  • Survivor Profile

    A Long Road Back

    Multiple myeloma survivor Gary Lambert deploys inventiveness and fortitude to deal with cancer.

    by Lindsey Konkel

  • Vaccines: Looking Within for Cancer Treatment

    Researchers are testing treatment vaccines that spur the immune system to attack cancer.

    by Stephen Ornes

  • Treatment Is Waiting

    For patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.

    by Sue Rochman

  • Yesterday & Today

    Taking Her Place

    Geraldine Ferraro, the first woman nominated for vice president on a major-party ticket, used her political prowess to advocate for women's equality. In 1998, she was diagnosed with multiple myeloma.

    by Sharlene George

  • African-Americans at Higher Risk for Multiple Myeloma

    Researchers aim to identify possible reasons.

    by Sue Rochman

  • Forward Look

    Paying a Steep Price

    New laws are pushing health insurers to make oral cancer drugs affordable.

    by Betty Russell

Advertisement
Advertisement

From the AACR

  • Genetics of Prostate Cancer

    Although there are many factors that can increase the risk for prostate cancer, for a significant number of men it can be inherited.

  • Liver Cancer Prevention

    The leading cause of liver cancer is infection with the hepatitis B virus or the hepatitis C virus.

  • Immunotherapy Resistance

    The majority of patients’ cancers don't respond to immune checkpoint inhibition. The reasons for this resistance remain unclear.

Advertisement

Video

Handle With Care

Advertisement

social media

donate to the AACR